Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating LIV-GAMMA SN Injectable for ABO-incompatible liver transplantation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• LIV-GAMMA SN Inj.

Snippet

Sponsor: SK Plasma Co., Ltd. | Conditions: Liver Transplantation | Phase 2 | Status: TERMINATED